Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02331368
What this trial is testing

Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT00002697
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT02773485
What this trial is testing

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tata Memorial Hospital 155
Testing effectiveness (Phase 2)Study completedNCT00186394
What this trial is testing

High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-Hodgkin
Stanford University 35
Testing effectiveness (Phase 2)Study completedNCT00787566
What this trial is testing

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Shin Nippon Biomedical Laboratories, Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT00066222
What this trial is testing

Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 72
Large-scale testing (Phase 3)Study completedNCT00952341
What this trial is testing

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 421
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418866
What this trial is testing

FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Fudan University 70
Large-scale testing (Phase 3)UnknownNCT02085694
What this trial is testing

Lactobacillus Brevis CD2 Preventing Oral Mucositis

Who this might be right for
Mucositis
Catholic University of the Sacred Heart 10
Testing effectiveness (Phase 2)Study completedNCT04478123
What this trial is testing

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Who this might be right for
Multiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00276809
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 30
Large-scale testing (Phase 3)Study completedNCT01015183
What this trial is testing

Prevention Chemotherapy Induced Mucositis by Zinc Sulfate

Who this might be right for
MucositisBone Marrow Transplantation
Tehran University of Medical Sciences 60
Testing effectiveness (Phase 2)UnknownNCT03061656
What this trial is testing

Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
Samsung Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00614484
What this trial is testing

Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer

Who this might be right for
Locally Advanced Non-Small Cell Lung Cancer
Loma Linda University 28
Large-scale testing (Phase 3)Study completedNCT00004921
What this trial is testing

High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery

Who this might be right for
Ovarian Cancer
EBMT Solid Tumors Working Party
Testing effectiveness (Phase 2)Study completedNCT00497809
What this trial is testing

Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia

Who this might be right for
Breast CancerNeutropenia
AviGenics 189
Testing effectiveness (Phase 2)Study completedNCT00004898
What this trial is testing

Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
Northwestern University 6
Large-scale testing (Phase 3)Study completedNCT01456169
What this trial is testing

Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

Who this might be right for
Essential Hypertension
Takeda 507
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00003269
What this trial is testing

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganLung Cancer+3 more
Scripps Health 20
Next Page